Central Trust Company’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19
Closed -$319 1509
2025
Q2
$319 Hold
19
﹤0.01% 1412
2025
Q1
$335 Hold
19
﹤0.01% 1420
2024
Q4
$462 Hold
19
﹤0.01% 1407
2024
Q3
$706 Hold
19
﹤0.01% 1342
2024
Q2
$905 Hold
19
﹤0.01% 1343
2024
Q1
$728 Hold
19
﹤0.01% 1335
2023
Q4
$593 Hold
19
﹤0.01% 1347
2023
Q3
$764 Buy
+19
New +$890 ﹤0.01% 1323
2022
Q3
Sell
-5
Closed 1411
2022
Q2
$0 Hold
5
﹤0.01% 1452
2022
Q1
$0 Buy
+5
New +$372 ﹤0.01% 1476

Other funds holding STAA

Central Trust Company's STAA Position: Q3 2025 in Review

Central Trust Company sold out of STAAR Surgical (STAA) in Q3 2025, closing a stake of 19 shares — an estimated $319 sold.

Central Trust Company first reported a position in STAA in Q1 2022 and held it in 10 quarters. The position peaked at $905 in Q2 2024. 196 funds tracked by Wall St. Rank hold STAA as of Q3 2025.

  • Central Trust Company reported no remaining STAAR Surgical position as of Q3 2025 after selling out during the quarter.
  • Central Trust Company sold 19 STAAR Surgical shares in Q3 2025, an estimated $319.
  • Central Trust Company first reported a position in STAAR Surgical in Q1 2022 and held it in 10 quarters.
  • Central Trust Company's STAAR Surgical position peaked at $905 in Q2 2024.
  • 196 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2025.

Based on Central Trust Company's 13F filing for Q3 2025, filed 6 Nov 2025.